Defining the concept of fair pricing for medicines

Abstract

Defining the concept of fair pricing for medicines Suerie Moon and colleagues consider what makes a fair price for both buyers and sellers H igh and rising prices of medicines have attracted public concern from the poorest to richest countries. For example, of 1500 patient groups surveyed in 78 countries, only 9% believed that pharmaceutical companies were "excellent or good" at having "fair pricing policies". This figure has hovered between 11% and 15% since the survey began in 2011.